pharma · Multiple Myeloma · generalized myasthenia gravis · RNAC
Cartesian Therapeutics
Cartesian Therapeutics is a pharma organization headquartered in Frederick, USA. It trades on NYSE under ticker RNAC. Primary therapeutic focus areas include Multiple Myeloma, generalized myasthenia gravis, Myasthaenia G
7495 New Horizon Way, Frederick, Maryland 21703, US HQ
2016 Founded
89 Employees
Public company Type
RNAC · NYSE Ticker
Company details
- Status
- Public
- HQ
- 7495 New Horizon Way, Frederick, Maryland 21703, US
- Founded
- 2016
- Employees
- 89
- Programs
- 12
- Drugs
- 4
- Patents
- 4
Decartes-08
Phase 3 · mab · Myasthaenia Gravis
Decartes-08 for Myasthaenia Gravis is a Phase 3 program (mab) at Cartesian Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code RNAC-MG-002 (AURORA)
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Cartesian Therapeutics
- Phase
- Phase 3
- Modality
- mab
- Indication
- Myasthaenia Gravis
- Status
- active
- Trials
- 1